Blomqvist, C. (1992) “FEC (5-Fluorouracil-Epirubicin-Cyclophosphamide) Monthly Versus FEC Weekly in Metastatic Breast Cancer: First results of a randomized trial”, Acta Oncologica, 31(2), pp. 231–236. doi: 10.3109/02841869209088908.